Over the years, Bioresis has built its strength as a bio-technology company by developing  its Research and Development capabilities. Decades of research and development efforts  have enabled it to develop its  proprietary manufacturing process  Multi-Stage Alcohol-Free Extraction ( M-SAFE™) Technology.

Bioresis’ years of close research collaboration with the Shanghai Military University Hospital II has enabled it to build a wealth of  expertise in the use of medicinal mushrooms for conjunctive therapy.

As earth’s natural recyclers who help in the process of bio-degrading dead plants , ABM and other fungi tend to have a build up of toxic heavy metals and bacteria. Though the content of beta glucans are very high in ABM mushroom compared to yeast, it is a challenge for manufacturers of beta glucan to ensure an extract which is free of these toxic substances.

With Bioresis’ cutting-edge M-SAFE™ technology, Bioresis has successfully produced  a  proprietary Halal aqueous extract which is high in beta glucans without the toxic heavy metals and microorganisms commonly present in mushrooms.

These successful results has been validated by accredited independent laboratories in Malaysia through heavy metal and microbial tests.

This proprietary Halal aqueous extract of ABM is called the Organic Beta-Matrix Complex™. It has the highest concentration of  beta 1,3/1,6 D- glucans, egosterol and other phytonutrients. The Organic Beta-Matrix Complex™ is readily bio-available for the body to absorb and harness the health benefits of beta glucan.